Genomes are sequenced faster than anyone can read them.
Sequencing a genome is now fast and cheap. Making sense of one is neither. That gap — the interpretation bottleneck — slows the labs and research teams who read genomes, and the answers that depend on them. It's the problem we're working to close.
The cost moved from sequencing to reading
Whole-genome sequencing has reached the ~$200 threshold, but interpretation still depends on scarce specialists doing slow, manual work. Genomic data is now growing faster than human teams can classify it — so the constraint is no longer the machine, it's the expert hours.
- Largest cost
- Expert manpower — not sequencing — is the biggest cost in genome-sequencing services.
- Kingsmore et al., 2024
- < 1/4
- of genetic counselors' time is spent in face-to-face patient care; the rest is analytical and administrative.
- Duong & Solomon, 2025
- 6–25%
- added diagnostic yield from multidisciplinary teams — they help, but don't remove the bottleneck.
- Ma et al., 2024
Years of waiting — and it isn't benign
Diagnostic delay in genetic disease is linked to excess morbidity and mortality, anxiety, repeated ineffective testing, and prolonged exposure to the wrong treatments (Tinker et al., 2024; Garrison et al., 2025). The wait is measured in years, and some groups wait far longer.
Five constraints keep interpretation slow
The bottleneck isn't one problem — it's a stack of them. Each compounds diagnostic delay and uneven access, and each is documented across recent literature.
Specialist shortage
There are too few genetics experts for testing demand, so access and triage slow to a crawl (Duong & Solomon, 2025).
Manual interpretation doesn't scale
Clinically informed, hand-curated variant analysis cannot keep pace with genome-scale volumes (Duong & Solomon, 2025; Costa et al., 2025).
Data complexity
Whole-genome datasets are massive and full of difficult variant classes, so real signal gets missed or delayed (Ho et al., 2026).
System fragmentation
Poor interoperability and uneven standards produce inconsistent interpretation across labs and sites (Ho et al., 2026).
Concentrated expertise
Interpretation capacity sits in a few large centers, deepening geographic and access inequity (Olivucci et al., 2024).
Built to help interpretation keep pace with sequencing
GeneGenius is the interpretation layer between sequencing and the specialist — built to relieve exactly these constraints. Performance figures are company-reported and for research use only.
Minutes, not weeks
A raw VCF or FASTQ becomes an evidence-linked, ACMG/AMP-aligned research report in minutes — directly attacking manual-interpretation lag.
What AI can — and can't — fix
The evidence is clear on both sides: AI is well suited to relieving parts of the bottleneck, but it does not replace expert review. That's why GeneGenius keeps a qualified professional in the loop at every step. It augments the expert; it does not replace them.
Well suited to automation
- Triage and prioritize variants across large case volumes
- Match phenotype to gene from clinical notes and HPO terms
- Surface literature-grounded, evidence-linked context
- Produce reproducible outputs without fatigue
Still needs an expert
- Resolve VUS and hard cases without expert oversight
- Replace clinical judgment or final interpretation
- Escape the need for governance, bias, and privacy controls
- Generalize blindly across underrepresented populations
Where the field is going: the strongest near-term evidence favors moving genomics earlier in the pathway. First-line genome sequencing shortens time to diagnosis (Wigby et al., 2024), rapid sequencing in the ICU changed management in 26% of cases with net savings per child (Kingsmore et al., 2024), and trials like TRIAGE-GS (Stanley et al., 2025) and GT4BD (Chaigneau et al., 2025) are testing genomics-first pathways now.
Research Use Only
GeneGenius is for research use only (RUO) and is not intended for use in diagnostic procedures or clinical decision-making. Analytical capabilities are under ongoing validation.
See interpretation move at the speed of sequencing.
Explore a sample walkthrough, or tell us where interpretation slows your team down.
Explore other services